Photothermal colloid antibodies for shape-selective recognition and killing of microorganisms by Madden, Leigh A.. et al.
Photothermal Colloid Antibodies for Shape-Selective Recognition and 
Killing of Microorganisms 
Josef Borovička†, William J. Metheringham‡, Leigh A. Madden§, Christopher D. Walton‡, 
Simeon D. Stoyanov#⊥, and Vesselin N. Paunov*†  
 
†Surfactant and Colloid Group, Department of Chemistry, ‡Department of Physics, and 
§Department of Biology, University of Hull, Cottingham Road, HU6 7RX Hull, United 
Kingdom 
# Unilever R&D Vlaardingen, Olivier van Noortlaan 120, 3133 AT Vlaardingen, The 
Netherlands, and Laboratory of Physical Chemistry and Colloid Science, Wageningen 
University, 6703 HB Wageningen, The Netherlands 
⊥ Department of Mechanical Engineering, University College London, Torrington Place, 
London WC1E 7JE, United Kingdom 
 
Abstract 
We have developed a class of selective antimicrobial agents based on the recognition of the 
shape and size of the bacterial cells. These agents are anisotropic colloid particles fabricated 
as negative replicas of the target cells which involve templating of the cells with shells of 
inert material followed by their fragmentation. The cell shape recognition by such shell 
fragments is due to the increased area of surface contact between the cells and their matching 
shell fragments which resembles antibody–antigen interaction. We produced such “colloid 
antibodies” with photothermal mechanism for shape-selective killing of matching cells. This 
was achieved by the subsequent deposition of (i) gold nanoparticles (AuNPs) and (ii) silica 
shell over yeast cells, which were chosen as model pathogens. We demonstrated that 
fragments of these composite AuNP/silica shells act as “colloid antibodies” and can bind to 
yeast cells of the same shape and size and deliver AuNPs directly onto their surface. We 
showed that after laser irradiation, the localized heating around the AuNPs kills the microbial 
cells of matching shape. We confirmed the cell shape-specific killing by photothermal colloid 
antibodies in a mixture of two bacterial cultures of different cell shape and size. This 
approach opens a number of avenues for building powerful selective biocides based on 
combinations of colloid antibodies and cell-killing strategies which can be applied in new 
antibacterial therapies. 
  
The discovery of antibiotics has enabled the successful treatment of many infectious diseases. 
However, due to extensive use of antibiotics in recent decades, many pathogenic bacteria 
have developed multiple resistances to a number of antibiotics.(1-4) Development of novel 
strategies for combating multiple antibiotic resistant pathogens is recognized as a major 
challenge of modern medicine. 
Here, we are introducing a new class of antibiotic agents based on colloid particles, which are 
capable of recognition and binding to bacterial cells based on their shape and size, which was 
used for their selective killing by photothermal therapy. Surface recognition of bacteria based 
on the cell morphology has already been demonstrated in biosensors based on 
microorganism-imprinted surfaces.(5-8) Key–lock interactions have also been used in non-
biological colloidal systems for programmable self-assembly of colloid particles into 
composite clusters.(9, 10) Recently, several teams have looked into the encapsulation of cells 
in inorganic shells to create novel microstructures.(11-18) 
 
Figure 1.  
In this study we created the colloid analogue of antibodies which recognize the shape of 
target cells by fabricating silica shell fragments templating the cell surface. We produced 
such shell fragments by depositing silica by a sol–gel process onto the surface of target cells, 
forming core–shell particles. This was followed by their fragmentation by mild ultrasonic 
treatment and further removal of the cells’ cores by a bleaching process. 
 
Figure 2.  
Figure 1A shows schematically the fabrication steps of such shell fragments after pre-coating 
of the target cells with gold nanoparticles. The surfaces of these shell fragments can be 
treated further in order to increase the specific affinity of the shell fragment to the matching 
bacterial species. We demonstrated that even without biospecific interactions, the shell 
fragments recognize the target cells and bind preferentially to them due to the increased area 
of surface contact, which resembles the antibody–antigen interaction. However, in our case 
the colloid particle recognizes the cell of matching shape, hence the term “colloid antibody”. 
This strategy allows for selective killing of bacterial cells with matching colloid antibodies by 
combining the cell recognition with the delivery of biocidal agent directly to the target cell 
surface. The latter can be achieved, for example, by loading the colloid antibody with 
antibacterial payload. Here we demonstrate selective killing of target microbial cells by 
delivery of gold nanoparticles (AuNPs) onto their surfaces by photothermal treatment. When 
AuNPs are irradiated with light at a frequency which is resonant with their surface plasmon 
resonance, the absorbed light energy is converted into heat. This effect has been utilized in 
the so-called photothermal therapy to heat and consequently kill cancer cells;(19-27) it has 
also been used to kill bacteria(28-33) and damage viruses.(25-27) We demonstrate the action 
of these “photothermal” colloid antibodies powered by the localized heating of the AuNPs 
delivered directly onto the surface of the target microorganisms. The cells recognition 
combined with the photothermal treatment leads to their selective killing in a mixture with 
other non-matching microorganisms. We envisage that this strategy could also work for 
selective deactivation of viruses. 
 Figure 3.  
Figure 1B illustrates the principle of action of such photothermal colloid antibodies (PCAs) 
in a mixture of bacteria of different morphologies. We fabricated PCAs matching the shape 
of yeast cells, Saccharomyces cerevisiae, which we used as model target microorganisms. 
The silica shells were templated over yeast cells, pre-coated with 10 nm AuNPs. Silica was 
deposited on the cells by a Stöber process, which led to integration of the AuNPs on the inner 
silica shell surface. The silica shells were partially fragmented by ultrasonic bath treatment 
and cleaned from the yeast cell cores by oxidation with Piranha solution. Here we describe 
the fabrication methodology of PCAs and the tests with them in more details (see also 
Supporting Information). 
The AuNPs were synthesized as follows.(34) All reagents were purchased from Sigma and 
used as supplied. A mixture of 79 mL of Milli-Q water and 100 μL of 10 wt% chloroauric 
acid (98%) was heated to 60 °C and rapidly mixed with vigorous stirring with a solution 
prepared from 4 mL of 1 wt% aqueous trisodium citrate, 100 μL of 1 wt% tannic acid, 0.5 
mL of 0.025 M potassium carbonate, and 20 mL of Milli-Q water. The mixture was heated 
until boiling, which produces a AuNPs dispersion, and subsequently cooled at room 
temperature. The PCAs for yeast cells were fabricated as follows. First, 25 mL of the AuNP 
dispersion was combined with 25 mL of 10 mg/mL of aqueous poly(allylamine 
hydrochloride) (PAH, 15 kDa, from Sigma) and agitated in an ultrasonic bath for 20 min. 
Next, 1.5 g (wet weight) of hydrated baker’s yeast cells (from a local supermarket) was added 
to the AuNPs/PAH solution and incubated with shaking for 10 min. This was followed by 
triple centrifugation and washing with Milli-Q water, leaving pink pellets of the AuNP-
coated yeast cells which were then redispersed in 3 mL of 1:1 methanol/water mixture. 
Finally, 0.25 mL of 25% ammonia as catalyst and 2.5 mL of tetraethylorthosilicate, both from 
Sigma, were added to the cell suspension and then agitated for 3 h at 25 °C to form silica 
shells.(18) The product was recovered by centrifugation and washed three times with 
methanol following two washing steps with deionized water. Afterward, the resulting pellet 
was dried overnight at 105 °C. The yeast core/silica shell particles were washed with Milli-Q 
water, and the sediment was exposed to 15 mL of Piranha solution (3:1 concentrated sulfuric 
acid and hydrogen peroxide) in order to remove the organic templates. The resulting shells 
were washed three times with water. Microscopy observation revealed that the Piranha 
solution treatment led to partial fragmentation of the silica shells which was further aided by 
their incubation in an ultrasonic bath for 10 min. The silica shell fragments were 
fluorescently tagged with Rhodamine B isothiocyanate (RBITC) in order to facilitate the 
identification of the recognition instances with the target microorganism. This was performed 
via a 1 h incubation in a solution of 10% 3-aminopropyltriethoxysilane in toluene. A triple 
washing of the silica fragments with methanol was then followed by incubation in 1 mM 
solution of RBITC in methanol for 3 h, multiple washings with methanol, and redispersing in 
water. Figure 2 shows typical SEM and TEM images of the AuNP-covered yeast cells and 
their matching shell fragments at different stages of fabrication of the PCAs. Fresh yeast and 
Bacillus subtilis cells were each washed with water and gently centrifuged to produce a 
pellet. About 0.02 g wet weight of each of the microorganism pellets were then dispersed in 5 
mL water, to which the sediment of 10 mL of PCA dispersion was added and agitated for 10 
min. We designed a test experiment for selective killing of yeast cells by PCAs in a mixture 
with B. subtilis, which is a rod-like bacterium (see Figure 1B). The model system was placed 
in a custom-made cylindrical glass cuvette with inner diameter 2 mm and length 20 mm, and 
the sample was irradiated across its length with a Nd:YVO4 laser (model AOT) at 532 nm. 
The laser pulse duration was 2 ns full width at half-maximum (fwhm) with energy ∼10 μJ 
and a pulse repetition frequency of 20 kHz. 
 
Figure 4.  
The viability of the microorganisms was tested using fluorescein diacetate (FDA). A 10 mL 
aliquot of the FDA in acetone (10 mg/mL) was added to the irradiated sample, and the 
suspension was agitated for 20 min and examined using fluorescence microscopy, where the 
viable cells emitted green fluorescence due to internal hydrolysis of the FDA to fluorescein 
by the cell esterases. We also conducted three control experiments. These included testing the 
viability of cells which were not incubated with PCAs and/or treated by a laser. We examined 
the viability of the microorganisms which were incubated with PCAs but were not irradiated, 
and finally we also studied the effect of the exposure to PCAs and laser irradiation in a binary 
microbial mixture. Figure 3 shows a typical set of micrographs, which show over 85% 
specific recognition and killing in a mixture of two microorganisms by PCA. A summary of 
the experiments can be found in Figure 4. The photothermal effect of the AuNPs on PCAs by 
laser irradiation led to disruption of the cell walls of matching yeast cells and their death 
while the B. subtilis cells retained their viability. 
In summary, we have fabricated and demonstrated the selective bactericidal action based on 
the recognition of microbial shape by colloid antibodies. Selective killing based on cell shape 
recognition was achieved in a mixture of microorganisms combined with a photothermal 
effect. We anticipate that similar colloid antibodies can potentially become a powerful 
weapon in the fight against antibiotic-resistant bacteria as well as some viruses against which 
current medicine is powerless. They can also find applications as non-toxic antibacterial 
agents, preventing growth of harmful bacteria in various formulations. 
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